Dr. Priyamvada Singh, MD

Dr. Singh practices at Executive Health - HOPD in Columbus, Ohio.

Dr. Singh's NPI, 1881957462, was assigned on June 19, 2012. Dr. Singh holds Ohio license 35.131561.

Dr. Singh's primary practice is Executive Health - HOPD, at 300 W 10th Ave, Columbus, OH 43210.

Dr. Singh's primary practice is Executive Health - HOPD in Columbus, Ohio. Dr. Singh is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Singh to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Singh's licenses on file in 2 states: Ohio and Massachusetts.

CMS data shows 661 Medicare services from Dr. Singh across 7 procedure codes in 2024, for 254 Medicare patients. Medicare paid $53,235 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 254 Medicare patients who saw Dr. Singh in 2024. The largest group is under 65, with 129 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 5.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 59, with 44% women.

In 2024, Dr. Singh wrote 2,054 Medicare Part D claims for 248 patients. 93% of them were for generic drugs. CMS names the drug for 1,892 of them, across 30 drugs with 11 or more claims each, at $295,003 in total drug cost. In 2023, CMS named 1,683 claims across 29 drugs.

Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth.

Dmand AI links 40 papers to Dr. Singh, published from 2011 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Kidney Transplantation, Transplant Recipients and Acute Kidney Injury. Dr. Singh has published most often in Clin Transplant. Dr. Singh's most frequent co-authors are Todd E. Pesavento, MD, Charles M. Gibson, MD and Varun Kumar.

CMS Open Payments shows 13 general payments to Dr. Singh from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Merck Sharp & Dohme Corporation paid the most, $77.